These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26423040)

  • 1. Structural Optimization of Ghrelin Receptor Inverse Agonists to Improve Lipophilicity and Avoid Mechanism-Based CYP3A4 Inactivation.
    Takahashi B; Funami H; Shibata M; Maruoka H; Koyama M; Kanki S; Muto T
    Chem Pharm Bull (Tokyo); 2015; 63(10):825-32. PubMed ID: 26423040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally active ghrelin receptor inverse agonists and their actions on a rat obesity model.
    Takahashi B; Funami H; Iwaki T; Maruoka H; Shibata M; Koyama M; Nagahira A; Kamiide Y; Kanki S; Igawa Y; Muto T
    Bioorg Med Chem; 2015 Aug; 23(15):4792-4803. PubMed ID: 26100441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and optimization of novel 4-[(aminocarbonyl)amino]-N-[4-(2-aminoethyl)phenyl]benzenesulfonamide ghrelin receptor antagonists.
    Pasternak A; Goble SD; deJesus RK; Hreniuk DL; Chung CC; Tota MR; Mazur P; Feighner SD; Howard AD; Mills SG; Yang L
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6237-40. PubMed ID: 19767208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Aminoalkyl nicotinamide derivatives as pure inverse agonists of the ghrelin receptor.
    Takahashi B; Funami H; Iwaki T; Maruoka H; Nagahira A; Koyama M; Kamiide Y; Matsuo T; Muto T; Annoura H
    Bioorg Med Chem Lett; 2015 Jul; 25(13):2707-12. PubMed ID: 25981690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor.
    Kung DW; Coffey SB; Jones RM; Cabral S; Jiao W; Fichtner M; Carpino PA; Rose CR; Hank RF; Lopaze MG; Swartz R; Chen HT; Hendsch Z; Posner B; Wielis CF; Manning B; Dubins J; Stock IA; Varma S; Campbell M; DeBartola D; Kosa-Maines R; Steyn SJ; McClure KF
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4281-7. PubMed ID: 22677316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ghrelin receptor modulators: a patent review (2011 - 2014).
    Costantino L; Barlocco D
    Expert Opin Ther Pat; 2014 Sep; 24(9):1007-19. PubMed ID: 25047815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amine-free melanin-concentrating hormone receptor 1 antagonists: Novel 1-(1H-benzimidazol-6-yl)pyridin-2(1H)-one derivatives and design to avoid CYP3A4 time-dependent inhibition.
    Igawa H; Takahashi M; Shirasaki M; Kakegawa K; Kina A; Ikoma M; Aida J; Yasuma T; Okuda S; Kawata Y; Noguchi T; Yamamoto S; Fujioka Y; Kundu M; Khamrai U; Nakayama M; Nagisa Y; Kasai S; Maekawa T
    Bioorg Med Chem; 2016 Jun; 24(11):2486-2503. PubMed ID: 27112449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists.
    McCoull W; Barton P; Brown AJ; Bowker SS; Cameron J; Clarke DS; Davies RD; Dossetter AG; Ertan A; Fenwick M; Green C; Holmes JL; Martin N; Masters D; Moore JE; Newcombe NJ; Newton C; Pointon H; Robb GR; Sheldon C; Stokes S; Morgan D
    J Med Chem; 2014 Jul; 57(14):6128-40. PubMed ID: 24967667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ghrelin--a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues.
    Chollet C; Meyer K; Beck-Sickinger AG
    J Pept Sci; 2009 Nov; 15(11):711-30. PubMed ID: 19787814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-Sulfonyl-4-acylpiperazines as selective cannabinoid-1 receptor (CB1R) inverse agonists for the treatment of obesity.
    Vachal P; Fletcher JM; Fong TM; Huang CC; Lao J; Xiao JC; Shen CP; Strack AM; Shearman L; Stribling S; Chen RZ; Frassetto A; Tong X; Wang J; Ball RG; Tsou NN; Hickey GJ; Thompson DF; Faidley TD; Nicolich S; Achanfuo-Yeboah J; Hora DF; Hale JJ; Hagmann WK
    J Med Chem; 2009 Apr; 52(8):2550-8. PubMed ID: 19320488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, evaluation, and comparison of ghrelin receptor agonists and inverse agonists as suitable radiotracers for PET imaging.
    Chollet C; Bergmann R; Pietzsch J; Beck-Sickinger AG
    Bioconjug Chem; 2012 Apr; 23(4):771-84. PubMed ID: 22372770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive metabolite trapping studies on imidazo- and 2-methylimidazo[2,1-b]thiazole-based inverse agonists of the ghrelin receptor.
    Kalgutkar AS; Ryder TF; Walker GS; Orr ST; Cabral S; Goosen TC; Lapham K; Eng H
    Drug Metab Dispos; 2013 Jul; 41(7):1375-88. PubMed ID: 23610086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ghrelin receptor: high constitutive activity and methods for developing inverse agonists.
    Els S; Beck-Sickinger AG; Chollet C
    Methods Enzymol; 2010; 485():103-21. PubMed ID: 21050913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Modulation of Ghrelin to Induce Weight Loss: Successes and Challenges.
    Schalla MA; Stengel A
    Curr Diab Rep; 2019 Sep; 19(10):102. PubMed ID: 31506846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design of dual peptides targeting ghrelin and Y2 receptors to regulate food intake and body weight.
    Kilian TM; Klöting N; Bergmann R; Els-Heindl S; Babilon S; Clément-Ziza M; Zhang Y; Beck-Sickinger AG; Chollet C
    J Med Chem; 2015 May; 58(10):4180-93. PubMed ID: 25905598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone secretagogue receptor antagonists.
    Costantino L
    Expert Opin Ther Pat; 2012 Jun; 22(6):697-700. PubMed ID: 22537050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of piperazine-bisamide GHSR antagonists for the treatment of obesity.
    Yu M; Lizarzaburu M; Beckmann H; Connors R; Dai K; Haller K; Li C; Liang L; Lindstrom M; Ma J; Motani A; Wanska M; Zhang A; Li L; Medina JC
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1758-62. PubMed ID: 20137933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the constitutive activity of the ghrelin receptor by use of pharmacological tools and mutagenesis.
    Mokrosiński J; Holst B
    Methods Enzymol; 2010; 484():53-73. PubMed ID: 21036226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.
    Pettersson H; Bülow A; Ek F; Jensen J; Ottesen LK; Fejzic A; Ma JN; Del Tredici AL; Currier EA; Gardell LR; Tabatabaei A; Craig D; McFarland K; Ott TR; Piu F; Burstein ES; Olsson R
    J Med Chem; 2009 Apr; 52(7):1975-82. PubMed ID: 19338356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-aminopropanamide as human cannabinoid-1 receptor (CB1R) inverse agonists.
    Du W; Jewell JP; Lin LS; Colandrea VJ; Xiao JC; Lao J; Shen CP; Bateman TJ; Reddy VB; Ha SN; Shah SK; Fong TM; Hale JJ; Hagmann WK
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5195-9. PubMed ID: 19632830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.